advanbiomed.com (ADVB) - Revenue and Sales Volume

Corporate emblem and logo of Advanced Biomed Inc. (ADVB)

The trading revenue dynamics of Advanced Biomed Inc (ADVB) on the GURU.Markets platform chart correlate with the company's dependence on the adoption rate of oncology tests and medical center support. The expansion of rapid screening through laboratory partnerships creates synergy, yet the current funding shortage and depletion of reserves are weighing on the share price. The value of 0.00 shows the latest reading of this indicator, highlighting the business's current financial stage of development.

Advanced Biomed Inc - ADVB Company Sales (period 03/07/2025 - 11/13/2026)

Analytical breakdowns for Advanced Biomed Inc

Summary company analysis:ADVB advanbiomed.com
Core merchandise of advanbiomed.com

The business model of Advanced Biomed Inc (ADVB) attracts investors with its scaling potential driven by the sale of disposable consumables. This indicator captures the dynamics of daily product sales revenue, reflecting actual cash flow. By analyzing the company's sales volume changes, one can assess the efficiency of the operating leverage as test cartridge production volumes increase. The stabilization of this metric confirms fundamental revenue resilience, eliminating the risk of a value trap provided that debt remains controlled.

Key competitors

Company Total Revenue BeiGene Oncology ONC|Revenue and Sales Volume HALO|Revenue and Sales Volume revmed.com (RVMD)|Revenue and Sales Volume AAPG (Ascentage Pharma)|CGON: Company Sales Volume|URGN: Company Sales|BCAX: Company Revenue|PSNL: Revenue and Sales Volume|erasca.com (ERAS) - Revenue and Sales Volume|Company Revenue Delcath Systems|Company Sales Volume YMAB (Y-mAbs Therapeutics Inc)|Revenue and Sales Volume AURA|Company Sales candeltx.com CADL|Revenue and Sales Volume ARAY (Accuray Incorporated)|SELLAS Life Sciences Group, Inc. (SLS) - Company Total Revenue|Actuate Therapeutics - Revenue and Sales Volume|CTOR (Citius Oncology Inc.) - Company Sales Volume|HURA (tuhurabio.com) - Company Sales|Protara Tx - Company Sales Revenue|FATE (Fate Therapeutics, Inc.) - Revenue and Sales Volume|Company Revenue WHWK|Revenue and Sales Volume TCRX|Company Gross Revenue championsoncology.com|Company Revenue XBiotech XBIT|CEL-SCI Corp. (CVM) - Company Total Revenue|OSTX - Company Revenue|Radiopharm Theranostics Ltd (RADX) - Company Sales|ARTV: Revenue and Sales Volume|Company Total Revenue Adlai Nortye (ANL)|VERU (Veru Pharma) - Revenue and Sales Volume|Company Sales Volume TPST (Tempest Therapeutics Corp)|Company Sales XLO (Xilio Therapeutics, Inc.)|RENB (renovarobio.com) - Company Sales Revenue|Revenue and Sales Volume MURA (Mural Oncology)|Company Gross Revenue Kairos Pharma Limited (KAPA)|OKUR - Company Revenue|GDTC (CytoMed Therapeutics) - Company Sales Volume|CRIS: Revenue and Sales Volume|Company Sales Apollomics|THAR (Tharimmune) - Revenue and Sales Volume|Revenue and Sales Volume Genprex Inc.|Revenue and Sales Volume CLDI|Sunshine Biopharma Inc. - Company Sales Volume|Xenetic Biosciences, Inc. - Company Sales|salariuspharma.com - Company Revenue|Purple Biotech Ltd. - Revenue and Sales Volume|AONC: Company Revenue|BGNE: Revenue and Sales Volume|Company Sales Checkpoint Therapeutics Inc|ELEV (Elevation Oncology, Inc.) - Revenue and Sales Volume|Revenue and Sales Volume iCAD Corp|Company Revenue Ikena Oncology, Inc. (IKNA)|Notable Labs Ltd - Company Sales Volume|Revenue and Sales Volume VIRX (Viracta Therapeutics, Inc.)|MOR - Company Sales|NAYA Biosciences - Revenue and Sales Volume|Company Total Revenue ascentage.com